1
Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I
Condition(s):Multiple Myeloma Stage ILast Updated:April 11, 2012Terminated
Multiple Myeloma Stage I: 860 Clinical Trials, Page 1 of 86
Hide Studies Not Open or Pending
2
Stage I Multiple Myeloma Treatment
Condition(s):Multiple MyelomaLast Updated:March 26, 2012Unknown status
3
Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation
Condition(s):Multiple Myeloma Stage ILast Updated:January 3, 2019Unknown status
4
Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma
Condition(s):Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:May 31, 2013Completed
5
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:July 4, 2012Completed
6
S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma; Plasma Cell NeoplasmLast Updated:March 25, 2015Completed
7
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:August 12, 2013Unknown status
8
Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma
Condition(s):Multiple Myeloma; PlasmocytomaLast Updated:October 2, 2009Completed
9
Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:October 3, 2022Completed
10
Bortezomib, Doxorubicin Hydrochloride Liposome, and Thalidomide as First-line Therapy in Treating Patients With Previously Untreated Stage I, II, or III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:February 23, 2017Completed